220 related articles for article (PubMed ID: 1385052)
1. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease.
Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M
Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052
[TBL] [Abstract][Full Text] [Related]
2. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase.
Morrison HM; Kramps JA; Afford SC; Burnett D; Dijkman JH; Stockley RA
Clin Sci (Lond); 1987 Jul; 73(1):19-28. PubMed ID: 2440636
[TBL] [Abstract][Full Text] [Related]
3. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
Culpitt SV; Maziak W; Loukidis S; Nightingale JA; Matthews JL; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133
[TBL] [Abstract][Full Text] [Related]
4. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
5. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D
Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
7. Intratracheally-instilled antileukoprotease and alpha 1-proteinase inhibitor: effect on human neutrophil elastase-induced experimental emphysema and pulmonary localization.
Rudolphus A; Kramps JA; Mauve I; Dijkman JH
Histochem J; 1994 Oct; 26(10):817-24. PubMed ID: 7883591
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutrophil elastase in CF sputum by L-658,758.
Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994
[TBL] [Abstract][Full Text] [Related]
9. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
10. Interaction of granulocyte proteases with inhibitors in pulmonary diseases.
Ohlsson K; Fryksmark U; Ohlsson M; Tegner H
Adv Exp Med Biol; 1984; 167():299-312. PubMed ID: 6201045
[TBL] [Abstract][Full Text] [Related]
11. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1.
Chan SC; Shum DK; Ip MS
Am J Respir Crit Care Med; 2003 Jul; 168(2):192-8. PubMed ID: 12702549
[TBL] [Abstract][Full Text] [Related]
12. Contribution of additional elastase inhibitors other than alpha 1-protease inhibitor and bronchial antileukoprotease to neutrophil elastase inhibiting capacity of bronchoalveolar lavage.
Abboud R; Tsang A; Taller M
Ann N Y Acad Sci; 1991; 624():315. PubMed ID: 2064232
[No Abstract] [Full Text] [Related]
13. Determination of elastase inhibitory activity of alpha 1-proteinase inhibitor and bronchial antileukoprotease: different results using insoluble elastin or synthetic low molecular weight substrates.
Kramps JA; Morrison HM; Burnett D; Dijkman JH; Stockley RA
Scand J Clin Lab Invest; 1987 Jun; 47(4):405-10. PubMed ID: 2440098
[TBL] [Abstract][Full Text] [Related]
14. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
Sathe S; Sakata M; Beaton AR; Sack RA
Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-antiproteinase balance in tracheal aspirates from neonates.
Sluis KB; Darlow BA; Vissers MC; Winterbourn CC
Eur Respir J; 1994 Feb; 7(2):251-9. PubMed ID: 7909297
[TBL] [Abstract][Full Text] [Related]
16. Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain.
Kramps JA; van Twisk C; Appelhans H; Meckelein B; Nikiforov T; Dijkman JH
Biochim Biophys Acta; 1990 Apr; 1038(2):178-85. PubMed ID: 2158823
[TBL] [Abstract][Full Text] [Related]
17. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Bergenfeldt M; Axelsson L; Ohlsson K
Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
[TBL] [Abstract][Full Text] [Related]
18. Studies of MR 889, a new synthetic proteinase inhibitor.
Luisetti M; Piccioni PD; Donnini M; Peona V; Pozzi E; Grassi C
Biochem Biophys Res Commun; 1989 Dec; 165(2):568-73. PubMed ID: 2597145
[TBL] [Abstract][Full Text] [Related]
19. Studies on the role of antileukoprotease in respiratory tract diseases.
Fryksmark U; Prellner T; Tegner H; Ohlsson K
Eur J Respir Dis; 1984 Apr; 65(3):201-9. PubMed ID: 6202540
[TBL] [Abstract][Full Text] [Related]
20. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema.
Llewellyn-Jones CG; Harris TA; Stockley RA
Am J Respir Crit Care Med; 1996 Feb; 153(2):616-21. PubMed ID: 8564107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
